Literature DB >> 86731

C.S.F. beta-endorphin in schizophrenia.

W Domschke, A Dickschas, P Mitznegg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86731     DOI: 10.1016/s0140-6736(79)92769-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  The fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders.

Authors:  V D Sanua
Journal:  J Prim Prev       Date:  1996-09

Review 2.  Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implications.

Authors:  D L Copolov; R D Helme
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

3.  Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.

Authors:  R Weizman; A Weizman; S Tyano; G Szekely; B A Weissman; Y Sarne
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Immunoreactive beta-endorphin and adrenocorticotropin in human cerebrospinal fluid.

Authors:  K Nakao; S Oki; I Tanaka; K Horii; Y Nakai; T Furui; M Fukushima; A Kuwayama; N Kageyama; H Imura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

5.  Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects.

Authors:  I Gil-Ad; Z Dickerman; S Amdursky; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 6.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

Review 7.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec

8.  Odor perception and hedonics in chronic schizophrenia and in first episode psychosis.

Authors:  Małgorzata Urban-Kowalczyk; Dominik Strzelecki; Janusz Śmigielski; Magdalena Kotlicka-Antczak
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-05       Impact factor: 2.570

9.  Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Dominik Strzelecki
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-15       Impact factor: 2.570

10.  Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Med Sci Monit       Date:  2020-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.